52 related articles for article (PubMed ID: 11387867)
1. [Inadequate pharmacotherapy in patients with obsessive-compulsive disorder].
Denys D; van Megen HJ; Westenberg HG
Ned Tijdschr Geneeskd; 2001 May; 145(19):914-8. PubMed ID: 11387867
[TBL] [Abstract][Full Text] [Related]
2. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
Rabinowitz I; Baruch Y; Barak Y
Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
[TBL] [Abstract][Full Text] [Related]
3. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
4. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
5. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive disorder and migraine with medication-overuse headache.
Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P
Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831
[TBL] [Abstract][Full Text] [Related]
7. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
Coric V; Taskiran S; Pittenger C; Wasylink S; Mathalon DH; Valentine G; Saksa J; Wu YT; Gueorguieva R; Sanacora G; Malison RT; Krystal JH
Biol Psychiatry; 2005 Sep; 58(5):424-8. PubMed ID: 15993857
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
9. [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment].
Iglesias Garcia C; Santamarina Montila S; Alonso Villa MJ
Actas Esp Psiquiatr; 2006; 34(4):277-9. PubMed ID: 16823689
[TBL] [Abstract][Full Text] [Related]
10. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical characteristics, co-morbidity and pharmacotherapy in adolescent schizophrenia patients with and without obsessive-compulsive disorder.
Poyurovsky M; Faragian S; Shabeta A; Kosov A
Psychiatry Res; 2008 May; 159(1-2):133-9. PubMed ID: 18406469
[TBL] [Abstract][Full Text] [Related]
12. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
[TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment.
Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A
J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621
[TBL] [Abstract][Full Text] [Related]
14. Chronic tics and Tourette syndrome in patients with obsessive-compulsive disorder.
Diniz JB; Rosario-Campos MC; Hounie AG; Curi M; Shavitt RG; Lopes AC; Miguel EC
J Psychiatr Res; 2006 Sep; 40(6):487-93. PubMed ID: 16289552
[TBL] [Abstract][Full Text] [Related]
15. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder.
Cullen B; Brown CH; Riddle MA; Grados M; Bienvenu OJ; Hoehn-Saric R; Shugart YY; Liang KY; Samuels J; Nestadt G
Depress Anxiety; 2007; 24(2):130-8. PubMed ID: 16892417
[TBL] [Abstract][Full Text] [Related]
16. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of obsessive-compulsive disorder: a review of findings in the light of diagnostic and metric limitations.
Towbin KE; Leckman JF; Cohen DJ
Psychiatr Dev; 1987; 5(1):25-50. PubMed ID: 2885832
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil.
Torresan RC; Ramos-Cerqueira AT; de Mathis MA; Diniz JB; Ferrão YA; Miguel EC; Torres AR
Compr Psychiatry; 2009; 50(1):63-9. PubMed ID: 19059516
[TBL] [Abstract][Full Text] [Related]
19. Nicotine treatment of obsessive-compulsive disorder.
Lundberg S; Carlsson A; Norfeldt P; Carlsson ML
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1195-9. PubMed ID: 15610934
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder in a dermatology outpatient clinic.
Demet MM; Deveci A; Taskin EO; Ermertcan AT; Yurtsever F; Deniz F; Bayraktar D; Ozturkcan S
Gen Hosp Psychiatry; 2005; 27(6):426-30. PubMed ID: 16271657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
